25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Tianda Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyze Tianda Pharmaceuticals Ltd together

I guess you are interested in Tianda Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tianda Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Tianda Pharmaceuticals Ltd

I send you an email if I find something interesting about Tianda Pharmaceuticals Ltd.

1. Quick Overview

1.1. Quick analysis of Tianda Pharmaceuticals Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Tianda Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$0.28
Expected worth in 1 year
HK$0.16
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
HK$-0.11
Return On Investment
-55.5%

For what price can you sell your share?

Current Price per Share
HK$0.19
Expected price per share
HK$0.16 - HK$0.2
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Tianda Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)
HK$0.19
Intrinsic Value Per Share
HK$-0.64 - HK$0.31
Total Value Per Share
HK$-0.37 - HK$0.59

2.2. Growth of Tianda Pharmaceuticals Ltd (5 min.)




Is Tianda Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$76.1m$84.1m-$8m-10.5%

How much money is Tianda Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.1m-$7m$3.9m126.2%
Net Profit Margin-4.5%-10.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Tianda Pharmaceuticals Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Tianda Pharmaceuticals Ltd?

Welcome investor! Tianda Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Tianda Pharmaceuticals Ltd.

First you should know what it really means to hold a share of Tianda Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tianda Pharmaceuticals Ltd is HK$0.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tianda Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tianda Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.28. Based on the TTM, the Book Value Change Per Share is HK$-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tianda Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.00-0.8%0.00-0.8%0.00-1.3%0.00-0.7%0.00-0.3%
Usd Book Value Change Per Share0.00-2.0%0.00-2.0%-0.01-4.2%0.00-1.4%0.00-0.7%
Usd Dividend Per Share0.000.2%0.000.2%0.000.6%0.000.2%0.000.2%
Usd Total Gains Per Share0.00-1.8%0.00-1.8%-0.01-3.7%0.00-1.1%0.00-0.5%
Usd Price Per Share0.03-0.03-0.03-0.03-0.04-
Price to Earnings Ratio-23.14--23.14--11.07-6.78-46.23-
Price-to-Total Gains Ratio-9.86--9.86--3.87--166.61--87.80-
Price to Book Ratio0.94-0.94-0.69-0.66-0.77-
Price-to-Total Gains Ratio-9.86--9.86--3.87--166.61--87.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.024434
Number of shares40926
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (40926 shares)-138.83-89.37
Gains per Year (40926 shares)-555.31-357.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
155-610-56571-429-367
2109-1220-1120143-858-724
3164-1830-1675214-1286-1081
4219-2440-2230285-1715-1438
5274-3050-2785357-2144-1795
6328-3660-3340428-2573-2152
7383-4270-3895499-3002-2509
8438-4880-4450571-3430-2866
9492-5490-5005642-3859-3223
10547-6100-5560713-4288-3580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%15.010.00.060.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%14.011.00.056.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.09.064.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%14.011.00.056.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Tianda Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.029-0.0290%-0.063+116%-0.020-30%-0.010-64%
Book Value Per Share--0.2750.2750%0.304-10%0.330-17%0.358-23%
Current Ratio--1.0991.0990%1.540-29%2.338-53%3.953-72%
Debt To Asset Ratio--0.3550.3550%0.399-11%0.319+11%0.229+55%
Debt To Equity Ratio--0.5500.5500%0.692-21%0.495+11%0.334+65%
Dividend Per Share--0.0030.0030%0.008-68%0.003-23%0.003-20%
Eps---0.011-0.0110%-0.019+70%-0.010-10%-0.004-61%
Free Cash Flow Per Share---0.054-0.0540%0.025-312%-0.040-26%-0.019-65%
Free Cash Flow To Equity Per Share---0.069-0.0690%0.012-676%-0.037-46%-0.016-77%
Gross Profit Margin--8.7198.7190%4.675+86%0.326+2578%-15.210+274%
Intrinsic Value_10Y_max--0.314--------
Intrinsic Value_10Y_min---0.643--------
Intrinsic Value_1Y_max---0.008--------
Intrinsic Value_1Y_min---0.047--------
Intrinsic Value_3Y_max--0.006--------
Intrinsic Value_3Y_min---0.156--------
Intrinsic Value_5Y_max--0.057--------
Intrinsic Value_5Y_min---0.283--------
Market Cap408507612.160-37%559010889.840559010889.8400%453658837.524+23%458388929.669+22%593239306.066-6%
Net Profit Margin---0.045-0.0450%-0.100+120%-0.045-1%-0.022-51%
Operating Margin---0.055-0.0550%-0.128+135%-0.056+4%-0.021-62%
Operating Ratio--1.0551.0550%1.128-7%1.062-1%1.032+2%
Pb Ratio0.690-37%0.9440.9440%0.693+36%0.660+43%0.769+23%
Pe Ratio-16.912+27%-23.143-23.1430%-11.071-52%6.780-441%46.227-150%
Price Per Share0.190-37%0.2600.2600%0.211+23%0.213+22%0.276-6%
Price To Free Cash Flow Ratio-3.520+27%-4.817-4.8170%8.289-158%-1.957-59%7.593-163%
Price To Total Gains Ratio-7.203+27%-9.857-9.8570%-3.871-61%-166.612+1590%-87.798+791%
Quick Ratio--0.8850.8850%1.350-34%1.646-46%3.408-74%
Return On Assets---0.026-0.0260%-0.050+91%-0.022-18%-0.010-64%
Return On Equity---0.041-0.0410%-0.087+113%-0.036-12%-0.016-60%
Total Gains Per Share---0.026-0.0260%-0.055+107%-0.017-36%-0.007-73%
Usd Book Value--76123612.60076123612.6000%84135521.200-10%91350483.692-17%98975520.771-23%
Usd Book Value Change Per Share---0.004-0.0040%-0.008+116%-0.003-30%-0.001-64%
Usd Book Value Per Share--0.0350.0350%0.039-10%0.042-17%0.046-23%
Usd Dividend Per Share--0.0000.0000%0.001-68%0.000-23%0.000-20%
Usd Eps---0.001-0.0010%-0.002+70%-0.001-10%-0.001-61%
Usd Free Cash Flow---14922486.800-14922486.8000%7038020.800-312%-11049977.016-26%-5162666.393-65%
Usd Free Cash Flow Per Share---0.007-0.0070%0.003-312%-0.005-26%-0.002-65%
Usd Free Cash Flow To Equity Per Share---0.009-0.0090%0.002-676%-0.005-46%-0.002-77%
Usd Market Cap52534078.924-37%71888800.43371888800.4330%58340526.506+23%58948816.355+22%76290574.760-6%
Usd Price Per Share0.024-37%0.0330.0330%0.027+23%0.027+22%0.035-6%
Usd Profit---3106333.000-3106333.0000%-7026171.982+126%-3024240.701-3%-1335503.477-57%
Usd Revenue--68426645.40068426645.4000%70304758.251-3%65702885.929+4%51064392.823+34%
Usd Total Gains Per Share---0.003-0.0030%-0.007+107%-0.002-36%-0.001-73%
 EOD+3 -5MRQTTM+0 -0YOY+20 -165Y+10 -2610Y+6 -30

3.3 Fundamental Score

Let's check the fundamental score of Tianda Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-16.912
Price to Book Ratio (EOD)Between0-10.690
Net Profit Margin (MRQ)Greater than0-0.045
Operating Margin (MRQ)Greater than0-0.055
Quick Ratio (MRQ)Greater than10.885
Current Ratio (MRQ)Greater than11.099
Debt to Asset Ratio (MRQ)Less than10.355
Debt to Equity Ratio (MRQ)Less than10.550
Return on Equity (MRQ)Greater than0.15-0.041
Return on Assets (MRQ)Greater than0.05-0.026
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Tianda Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.207
Ma 20Greater thanMa 500.190
Ma 50Greater thanMa 1000.216
Ma 100Greater thanMa 2000.229
OpenGreater thanClose0.190
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Tianda Pharmaceuticals Ltd

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It provides Chinese medicines, chemical drugs, biological and health products, and medical appliances covering therapy areas of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, anti-cancer, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces, and Chinese medicines; provision of Chinese medicine clinical and medical services; and trading of agricultural by-products. In addition, the company provides healthcare services, such as general TCM treatment, health preservation, and health management services, as well as personalized systems for disease diagnosis, treatment, and prevention along with health preservation. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

Fundamental data was last updated by Penke on 2024-10-28 11:13:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Tianda Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Tianda Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -4.5% means that $-0.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is -4.5%. The company is making a loss. -1
  • The TTM is -4.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-4.5%TTM-4.5%0.0%
TTM-4.5%YOY-10.0%+5.5%
TTM-4.5%5Y-4.5%0.0%
5Y-4.5%10Y-2.2%-2.3%
4.3.1.2. Return on Assets

Shows how efficient Tianda Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tianda Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Assets means that Tianda Pharmaceuticals Ltd generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2.6%0.0%
TTM-2.6%YOY-5.0%+2.4%
TTM-2.6%5Y-2.2%-0.5%
5Y-2.2%10Y-1.0%-1.2%
4.3.1.3. Return on Equity

Shows how efficient Tianda Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tianda Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4.1% Return on Equity means Tianda Pharmaceuticals Ltd generated $-0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is -4.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM-4.1%0.0%
TTM-4.1%YOY-8.7%+4.6%
TTM-4.1%5Y-3.6%-0.5%
5Y-3.6%10Y-1.6%-1.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Tianda Pharmaceuticals Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Tianda Pharmaceuticals Ltd is operating .

  • Measures how much profit Tianda Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tianda Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -5.5% means the company generated $-0.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is -5.5%. The company is operating very inefficient. -2
  • The TTM is -5.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5.5%TTM-5.5%0.0%
TTM-5.5%YOY-12.8%+7.4%
TTM-5.5%5Y-5.6%+0.2%
5Y-5.6%10Y-2.1%-3.6%
4.3.2.2. Operating Ratio

Measures how efficient Tianda Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are $1.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is 1.055. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.055. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.055TTM1.0550.000
TTM1.055YOY1.128-0.074
TTM1.0555Y1.062-0.008
5Y1.06210Y1.032+0.030
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Tianda Pharmaceuticals Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Tianda Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.10 means the company has $1.10 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is 1.099. The company is just able to pay all its short-term debts.
  • The TTM is 1.099. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.099TTM1.0990.000
TTM1.099YOY1.540-0.441
TTM1.0995Y2.338-1.239
5Y2.33810Y3.953-1.615
4.4.3.2. Quick Ratio

Measures if Tianda Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tianda Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.88 means the company can pay off $0.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is 0.885. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.885. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.885TTM0.8850.000
TTM0.885YOY1.350-0.466
TTM0.8855Y1.646-0.761
5Y1.64610Y3.408-1.762
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Tianda Pharmaceuticals Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Tianda Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tianda Pharmaceuticals Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.35 means that Tianda Pharmaceuticals Ltd assets are financed with 35.5% credit (debt) and the remaining percentage (100% - 35.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is 0.355. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.355. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.355TTM0.3550.000
TTM0.355YOY0.399-0.044
TTM0.3555Y0.319+0.036
5Y0.31910Y0.229+0.090
4.5.4.2. Debt to Equity Ratio

Measures if Tianda Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tianda Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 55.0% means that company has $0.55 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tianda Pharmaceuticals Ltd:

  • The MRQ is 0.550. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.550. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.550TTM0.5500.000
TTM0.550YOY0.692-0.142
TTM0.5505Y0.495+0.055
5Y0.49510Y0.334+0.161
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Tianda Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Tianda Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -23.14 means the investor is paying $-23.14 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tianda Pharmaceuticals Ltd:

  • The EOD is -16.912. Based on the earnings, the company is expensive. -2
  • The MRQ is -23.143. Based on the earnings, the company is expensive. -2
  • The TTM is -23.143. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.912MRQ-23.143+6.231
MRQ-23.143TTM-23.1430.000
TTM-23.143YOY-11.071-12.072
TTM-23.1435Y6.780-29.922
5Y6.78010Y46.227-39.448
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tianda Pharmaceuticals Ltd:

  • The EOD is -3.520. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.817. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.817. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.520MRQ-4.817+1.297
MRQ-4.817TTM-4.8170.000
TTM-4.817YOY8.289-13.107
TTM-4.8175Y-1.957-2.861
5Y-1.95710Y7.593-9.549
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Tianda Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tianda Pharmaceuticals Ltd:

  • The EOD is 0.690. Based on the equity, the company is cheap. +2
  • The MRQ is 0.944. Based on the equity, the company is cheap. +2
  • The TTM is 0.944. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.690MRQ0.944-0.254
MRQ0.944TTM0.9440.000
TTM0.944YOY0.693+0.251
TTM0.9445Y0.660+0.284
5Y0.66010Y0.769-0.109
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets917,291
Total Liabilities325,350
Total Stockholder Equity592,071
 As reported
Total Liabilities 325,350
Total Stockholder Equity+ 592,071
Total Assets = 917,291

Assets

Total Assets917,291
Total Current Assets344,208
Long-term Assets573,083
Total Current Assets
Cash And Cash Equivalents 162,442
Short-term Investments 8,432
Net Receivables 106,375
Inventory 65,148
Total Current Assets  (as reported)344,208
Total Current Assets  (calculated)342,397
+/- 1,811
Long-term Assets
Property Plant Equipment 413,310
Goodwill 95,230
Intangible Assets 20,677
Long-term Assets Other 13,973
Long-term Assets  (as reported)573,083
Long-term Assets  (calculated)543,190
+/- 29,893

Liabilities & Shareholders' Equity

Total Current Liabilities313,312
Long-term Liabilities12,038
Total Stockholder Equity592,071
Total Current Liabilities
Short-term Debt 102,170
Short Long Term Debt 96,492
Accounts payable 117,993
Other Current Liabilities 79,435
Total Current Liabilities  (as reported)313,312
Total Current Liabilities  (calculated)396,090
+/- 82,778
Long-term Liabilities
Capital Lease Obligations 8,747
Long-term Liabilities  (as reported)12,038
Long-term Liabilities  (calculated)8,747
+/- 3,291
Total Stockholder Equity
Common Stock215,004
Retained Earnings 70,919
Accumulated Other Comprehensive Income -58,514
Other Stockholders Equity 364,662
Total Stockholder Equity (as reported)592,071
Total Stockholder Equity (calculated)592,071
+/-0
Other
Capital Stock215,004
Cash and Short Term Investments 162,442
Common Stock Shares Outstanding 2,150,042
Current Deferred Revenue13,714
Liabilities and Stockholders Equity 917,291
Net Debt -48,845
Net Invested Capital 696,921
Net Working Capital 30,896
Property Plant and Equipment Gross 527,665
Short Long Term Debt Total 113,597



6.2. Balance Sheets Structured

Currency in HKD. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-31
> Total Assets 
189,999
191,939
196,436
191,749
219,849
220,309
233,618
202,350
407,605
438,225
461,756
990,845
1,007,845
914,871
932,490
921,017
956,169
904,120
1,045,308
996,769
933,123
1,133,461
1,164,151
1,088,468
917,291
917,2911,088,4681,164,1511,133,461933,123996,7691,045,308904,120956,169921,017932,490914,8711,007,845990,845461,756438,225407,605202,350233,618220,309219,849191,749196,436191,939189,999
   > Total Current Assets 
0
98,297
92,280
81,378
65,914
68,947
74,264
76,106
267,443
296,738
315,610
711,573
973,958
489,732
503,818
482,290
487,035
481,462
617,110
720,495
593,818
606,410
577,446
558,173
344,208
344,208558,173577,446606,410593,818720,495617,110481,462487,035482,290503,818489,732973,958711,573315,610296,738267,44376,10674,26468,94765,91481,37892,28098,2970
       Cash And Cash Equivalents 
19,908
84,572
78,376
76,414
59,885
58,127
63,470
66,142
138,934
135,378
181,367
557,018
412,142
426,139
427,264
158,366
394,301
399,316
493,154
384,909
302,018
234,985
334,001
340,277
162,442
162,442340,277334,001234,985302,018384,909493,154399,316394,301158,366427,264426,139412,142557,018181,367135,378138,93466,14263,47058,12759,88576,41478,37684,57219,908
       Short-term Investments 
109,508
76,591
70,990
60,337
46,384
46,679
43,152
57,596
102,456
148,910
121,179
1,138
322,548
243,457
252,216
225,819
0
1,539
4,488
57,954
3,905
2,973
14,583
3,167
8,432
8,4323,16714,5832,9733,90557,9544,4881,5390225,819252,216243,457322,5481,138121,179148,910102,45657,59643,15246,67946,38460,33770,99076,591109,508
       Net Receivables 
1,732
8,725
8,903
4,964
5,004
6,060
7,797
7,822
4,285
7,697
46,615
65,920
1,081
23,159
36,863
59,521
42,331
39,451
77,650
285,946
92,775
101,307
95,631
142,819
106,375
106,375142,81995,631101,30792,775285,94677,65039,45142,33159,52136,86323,1591,08165,92046,6157,6974,2857,8227,7976,0605,0044,9648,9038,7251,732
       Inventory 
0
0
0
0
1,026
1,743
2,268
1,743
2,734
4,664
4,170
87,351
7,846
33,310
28,812
38,584
41,681
35,432
36,324
48,777
48,374
64,393
74,894
48,193
65,148
65,14848,19374,89464,39348,37448,77736,32435,43241,68138,58428,81233,3107,84687,3514,1704,6642,7341,7432,2681,7431,0260000
   > Long-term Assets 
0
93,643
104,157
110,370
153,935
151,362
159,354
126,244
140,162
141,487
146,145
279,272
33,887
425,139
428,671
438,727
469,134
422,658
428,197
276,274
339,305
527,051
586,705
530,295
573,083
573,083530,295586,705527,051339,305276,274428,197422,658469,134438,727428,671425,13933,887279,272146,145141,487140,162126,244159,354151,362153,935110,370104,15793,6430
       Property Plant Equipment 
2,732
17,051
15,666
12,474
35,847
36,320
91,704
74,881
80,356
23,236
23,806
92,599
21,998
117,968
141,227
168,058
155,195
139,284
264,708
95,721
176,665
389,124
456,788
400,508
413,310
413,310400,508456,788389,124176,66595,721264,708139,284155,195168,058141,227117,96821,99892,59923,80623,23680,35674,88191,70436,32035,84712,47415,66617,0512,732
       Goodwill 
0
0
0
0
5,306
5,011
5,108
5,250
5,895
6,021
6,051
57,061
6,587
109,063
111,618
111,615
106,926
98,714
112,148
104,827
95,015
103,269
106,214
95,948
95,230
95,23095,948106,214103,26995,015104,827112,14898,714106,926111,615111,618109,0636,58757,0616,0516,0215,8955,2505,1085,0115,3060000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,073
36,232
17,779
8,991
0
0
0
0
0
000008,99117,77936,23230,0730000000000000000
       Intangible Assets 
0
0
0
0
1,557
1,472
1,413
5,250
5,895
6,021
6,051
67,427
6,587
98,766
86,161
73,040
59,137
41,036
33,344
66,735
66,318
27,785
21,937
6,126
20,677
20,6776,12621,93727,78566,31866,73533,34441,03659,13773,04086,16198,7666,58767,4276,0516,0215,8955,2501,4131,4721,5570000
       Other Assets 
0
4,843
0
0
0
0
4,279
3,640
3,897
5,692
3,815
14,200
5,301
99,343
89,665
84,764
117,379
107,391
113,862
38,409
10,015
19,571
30,133
31,345
0
031,34530,13319,57110,01538,409113,862107,391117,37984,76489,66599,3435,30114,2003,8155,6923,8973,6404,27900004,8430
> Total Liabilities 
1,309
1,548
1,988
1,828
3,966
4,565
7,541
8,240
9,833
25,611
22,855
148,612
137,899
139,671
117,428
132,609
109,435
91,156
159,723
185,803
173,360
376,752
375,076
434,226
325,350
325,350434,226375,076376,752173,360185,803159,72391,156109,435132,609117,428139,671137,899148,61222,85525,6119,8338,2407,5414,5653,9661,8281,9881,5481,309
   > Total Current Liabilities 
1,309
1,548
1,988
1,828
3,966
3,338
5,637
5,703
7,328
23,437
20,422
124,418
134,978
95,703
72,193
90,911
76,277
63,973
134,614
178,163
144,998
214,234
271,659
362,425
313,312
313,312362,425271,659214,234144,998178,163134,61463,97376,27790,91172,19395,703134,978124,41820,42223,4377,3285,7035,6373,3383,9661,8281,9881,5481,309
       Short-term Debt 
0
0
0
0
0
0
0
0
0
3,826
4,284
17,288
0
0
0
0
0
0
0
-12,824
608
18,894
61,862
70,304
102,170
102,17070,30461,86218,894608-12,824000000017,2884,2843,826000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
608
18,894
57,259
64,674
96,492
96,49264,67457,25918,89460800000000000000000000
       Accounts payable 
1,309
1,547
0
1,828
346
989
4,457
4,993
6,995
15,862
12,052
69,816
12,787
55,026
14,246
82,755
65,127
54,692
17,197
31,802
29,387
91,540
105,174
71,340
117,993
117,99371,340105,17491,54029,38731,80217,19754,69265,12782,75514,24655,02612,78769,81612,05215,8626,9954,9934,4579893461,82801,5471,309
       Other Current Liabilities 
0
1,548
1,988
1,828
3,966
3,338
1,180
710
333
334
4,085
353
122,191
40,677
57,947
8,156
11,150
9,280
117,417
146,361
38,589
39,719
104,623
109,048
79,435
79,435109,048104,62339,71938,589146,361117,4179,28011,1508,15657,94740,677122,1913534,0853343337101,1803,3383,9661,8281,9881,5480
   > Long-term Liabilities 
0
0
0
0
0
1,226
1,904
2,537
2,505
2,173
2,433
24,194
2,922
43,969
45,235
41,698
33,158
27,183
25,109
7,640
28,361
128,732
103,417
71,801
12,038
12,03871,801103,417128,73228,3617,64025,10927,18333,15841,69845,23543,9692,92224,1942,4332,1732,5052,5371,9041,22600000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,294
122,458
98,571
70,746
0
070,74698,571122,45820,29400000000000000000000
       Other Liabilities 
0
0
0
0
0
1,226
1,904
2,537
2,505
2,173
1,848
1,590
1,280
927
45,235
41,698
33,158
27,183
25,109
7,640
8,067
6,274
4,846
0
0
004,8466,2748,0677,64025,10927,18333,15841,69845,2359271,2801,5901,8482,1732,5052,5371,9041,22600000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,132
8,226
6,430
4,373
0
04,3736,4308,2268,13200000000000000000000
> Total Stockholder Equity
188,689
190,390
194,447
189,920
203,653
202,993
212,352
176,855
379,930
387,816
409,880
676,296
702,957
737,995
751,146
729,344
813,748
778,322
847,728
777,203
722,777
756,709
756,754
627,831
592,071
592,071627,831756,754756,709722,777777,203847,728778,322813,748729,344751,146737,995702,957676,296409,880387,816379,930176,855212,352202,993203,653189,920194,447190,390188,689
   Common Stock
45,955
45,947
45,947
45,947
50,685
50,685
50,685
50,685
93,506
93,506
93,506
187,012
187,012
187,012
187,012
187,012
215,064
215,064
215,048
215,004
215,004
215,004
215,004
215,004
215,004
215,004215,004215,004215,004215,004215,004215,048215,064215,064187,012187,012187,012187,012187,01293,50693,50693,50650,68550,68550,68550,68545,94745,94745,94745,955
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-18,092
-26,012
-23,457
-25,261
-23,965
-26,469
-32,261
-40,331
-54,762
-48,765
-54,024
4,750
0
-49,117
-58,514
-58,514-49,11704,750-54,024-48,765-54,762-40,331-32,261-26,469-23,965-25,261-23,457-26,012-18,0920000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
274,638
355,865
355,865
355,816
355,703
355,703
355,703
355,703
355,703
0
0355,703355,703355,703355,703355,703355,816355,865355,865274,638000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
190,390
194,447
189,920
203,653
202,993
212,352
176,855
379,930
294,310
334,466
515,296
378,782
357,999
358,193
363,100
419,164
385,316
471,704
400,455
-98,960
-35,091
541,750
364,662
364,662
364,662364,662541,750-35,091-98,960400,455471,704385,316419,164363,100358,193357,999378,782515,296334,466294,310379,930176,855212,352202,993203,653189,920194,447190,3900



6.3. Balance Sheets

Currency in HKD. All numbers in thousands.




6.4. Cash Flows

Currency in HKD. All numbers in thousands.




6.5. Income Statements

Currency in HKD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in HKD. All numbers in thousands.

Gross Profit (+$)
totalRevenue532,089
Cost of Revenue-276,557
Gross Profit255,532255,532
 
Operating Income (+$)
Gross Profit255,532
Operating Expense-284,555
Operating Income-29,023-29,023
 
Operating Expense (+$)
Research Development13,105
Selling General Administrative84,992
Selling And Marketing Expenses186,458
Operating Expense284,555284,555
 
Net Interest Income (+$)
Interest Income3,032
Interest Expense-4,946
Other Finance Cost-0
Net Interest Income-1,914
 
Pretax Income (+$)
Operating Income-29,023
Net Interest Income-1,914
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-25,694-32,352
EBIT - interestExpense = -33,969
-24,844
-19,209
Interest Expense4,946
Earnings Before Interest and Taxes (EBIT)-29,023-20,748
Earnings Before Interest and Taxes (EBITDA)7,384
 
After tax Income (+$)
Income Before Tax-25,694
Tax Provision--689
Net Income From Continuing Ops-25,005-25,005
Net Income-24,155
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses561,112
Total Other Income/Expenses Net3,3291,914
 

Technical Analysis of Tianda Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tianda Pharmaceuticals Ltd. The general trend of Tianda Pharmaceuticals Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tianda Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tianda Pharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.2 < 0.2 < 0.2.

The bearish price targets are: 0.1964 > 0.16 > 0.16.

Tweet this
Tianda Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tianda Pharmaceuticals Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tianda Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tianda Pharmaceuticals Ltd. The current macd is -0.00967041.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tianda Pharmaceuticals Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tianda Pharmaceuticals Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tianda Pharmaceuticals Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Tianda Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTianda Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tianda Pharmaceuticals Ltd. The current adx is 65.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tianda Pharmaceuticals Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Tianda Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tianda Pharmaceuticals Ltd. The current sar is 0.19075539.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tianda Pharmaceuticals Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tianda Pharmaceuticals Ltd. The current rsi is 40.21. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Tianda Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartTianda Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tianda Pharmaceuticals Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tianda Pharmaceuticals Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Tianda Pharmaceuticals Ltd Daily Stochastic Oscillator ChartTianda Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tianda Pharmaceuticals Ltd. The current cci is 7.91556728.

Tianda Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartTianda Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tianda Pharmaceuticals Ltd. The current cmo is -0.81817039.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tianda Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartTianda Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tianda Pharmaceuticals Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Tianda Pharmaceuticals Ltd Daily Williams %R ChartTianda Pharmaceuticals Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tianda Pharmaceuticals Ltd.

Tianda Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tianda Pharmaceuticals Ltd. The current atr is 0.00594495.

Tianda Pharmaceuticals Ltd Daily Average True Range (ATR) ChartTianda Pharmaceuticals Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tianda Pharmaceuticals Ltd. The current obv is 27,069,315.

Tianda Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartTianda Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tianda Pharmaceuticals Ltd. The current mfi is 100.00.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Tianda Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartTianda Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tianda Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Tianda Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tianda Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.207
Ma 20Greater thanMa 500.190
Ma 50Greater thanMa 1000.216
Ma 100Greater thanMa 2000.229
OpenGreater thanClose0.190
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Tianda Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tianda Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tianda Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tianda Pharmaceuticals Ltd

I send you an email if I find something interesting about Tianda Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tianda Pharmaceuticals Ltd.

Receive notifications about Tianda Pharmaceuticals Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.